Top 2023 global marijuana developments; Psychedelics momentum this year; Large federally supported cannabis study
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.
Support our work at https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
A bipartisan group of Wisconsin lawmakers formally filed a marijuana decriminalization bill that they hope can advance in the 2024 session.
New California and Washington State laws taking effect on Monday, January 1 will provide new employment-related protections for marijuana consumers.
John Hopkins University announced a new-large scale study that will track 10,000 medical cannabis patients over a year or more to investigate dosing, delivery methods, chemical composition of products and other issues—supported with a $10 million federal grant from the National Institute on Drug Abuse.
Marijuana legalization advancements in countries like Germany, Colombia, Luxembourg and others this year were among the top international cannabis policy developments of 2023.
The psychedelics policy reform movement saw historic wins in 2023—including federal research legislation being signed into law, state-legal psilocybin access rolling out, a first-ever congressional hearing and an FDA application to legalize MDMA.
/ FEDERAL
Senate Banking Committee Democrats included the panel’s passage of a cannabis banking bill on a list of 2023 highlights.
Rep. Steve Cohen (D-TN) tweeted, “A historic step by @POTUS in pardoning all federal marijuana possession cases, something I’ve been working towards for years. It’s more than ensuring policy keeps up with reality—it’s about correcting historic injustice, primarily against Black Americans.”
/ STATES
Ohio’s lieutenant governor is calling on lawmakers to put “safeguards” on legal recreational marijuana. Separately, regulators issued a recall of medical cannabis edibles over defective tamper-evident seals.
A New Hampshire representative tweeted, “Spent the day chatting with some cannabis farmers in Maine in preparation to defend my therapeutic home-grown bill. Fascinating discussion, learned so much. Therapeutic cannabis is medicine. Let’s make sure the program is protected in NH.”
Mississippi regulators said medical cannabis products that were placed on an administrative hold are being retested.
Alabama regulators are facing challenges from multiple companies that were denied medical cannabis business licenses, but they plan to issue licenses on Friday unless a court intervenes.
Vermont regulators published revised guidance on marijuana product registration.
Missouri regulators extended a variance for testing for vitamin E acetate in cannabis products.
Regulatory control of Virginia’s medical marijuana program is set to shift to the Cannabis Control Authority on Monday.
Several revisions to Oklahoma’s medical cannabis laws will take effect on Monday.
The New York Cannabis Control Board will meet on Friday.
—Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—/ INTERNATIONAL
Amsterdam, Netherlands officials are hosting a drug policy conference on January 26.
/ SCIENCE & HEALTH
A study of pain patients found that “most participants experienced their therapy with cannabinoids as more effective than their previous therapy. “
A study found that “psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility.”
/ BUSINESS
CannXperts hired a former top Oregon marijuana regulator as director of regulatory strategy and business development.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Read More Feedzy